Join
Live feed
·
PRReleasevia Quantisnow
Gilead Sciences Inc. logo

Gilead Strengthens Early Pipeline in Oncology and Inflammation Through the Acquisition of XinThera

ByQuantisnow·Wall Street's wire, on your screen.
GILD· Gilead Sciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GILD (Gilead Sciences Inc.) and more on Quantisnow.